A Multi-Country Comparison of Number Needed to Vaccinate for PCV20 and PCV15 in Infants. [PDF]
Dawson E, Tort MJ, Ta A, Rozenbaum MH.
europepmc +1 more source
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao +4 more
wiley +1 more source
Indirect effect and pneumococcal conjugate vaccines
L. Temimi
doaj +2 more sources
PCV20 in pediatric pneumococcal prevention: expanded coverage, remaining challenges. [PDF]
Principi N +3 more
europepmc +1 more source
From Photosynthesis to Photobiomodulation: Expanding the Therapeutic Potential of Light. [PDF]
Jürgen HH, Samuel JA.
europepmc +1 more source
Safety and Immunogenicity of SII's 10-Valent Pneumococcal Conjugate Vaccine (PCV10-SII) in Vietnamese Children Aged from 6 Weeks to 24 Months: An Open-Label, Single-Arm Bridging Study. [PDF]
Son VT +14 more
europepmc +1 more source
"Catch-Up Vaccinations Post-Stem Cell Transplant: A case series and review of the literature". [PDF]
Gaafar RM, Alamodi AM.
europepmc +1 more source
Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study. [PDF]
Carvalho N +14 more
europepmc +1 more source
Surveillance of invasive pneumococcal disease in Germany: surge in PCV13 serotypes and new challenges, 2017 to 2024. [PDF]
van der Linden MP, Pletz MW, Itzek A.
europepmc +1 more source
Aluminium adjuvants in vaccines and potential health effects: systematic review.
Doyon-Plourde P +6 more
europepmc +1 more source

